Cost effectiveness guidance

While analyses of cost-effectiveness of seasonal influenza vaccination have been widely assessed in high-income countries, there have been relatively few economic assessments of the value of seasonal influenza vaccination in low-resource settings [19–22]. Results of economic evaluations (e.g. costutility analyses) should be considered for comparison of influenza vaccination with equivalent evaluations of other health programmes and efficient allocation of resources in the health-care sector.

To optimize cost-effectiveness evaluation in national settings the WHO Guidance on the economic evaluation of influenza vaccination provides analysts with robust analytical methods and outlines relevant issues that can arise when evaluating influenza vaccination strategies.